Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism

被引:49
作者
Sahin, Y [1 ]
Dilber, S [1 ]
Kelestimur, F [1 ]
机构
[1] Erciyes Univ, Fac Med, Dept Obstet & Gynecol, TR-38039 Kayseri, Turkey
关键词
Diane; 35; finasteride; hirsutism;
D O I
10.1016/S0015-0282(00)01764-7
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To compare the clinical efficacy and safety of the combination of Diane 35 (2 mg of cyproterone acetate, and 35 mug of ethinyl estradiol) plus finasteride (5 mg), and Diane 35 alone in the treatment of hirsutism. Design: Prospective randomized clinical study. Setting: Outpatients in Erciyes University Medical School. Patient(s): Forty women with hirsutism were selected. Intervention(s): For 1 year, group I patients (n = 20) were treated with Diane 35 alone (2 mg of cyproterone acetate and 35 Ctg of ethinyl estradiol) daily on days 5 to 25 of the menstrual cycle and group 2 patients (n = 20) with Diane 35 plus finasteride (5 mg daily). Main Outcome Measure(s): Hirsutism was graded at 6-month intervals using the Ferriman-Gallwey method. The basal hormone levels of total and free testosterone (T), androstenedione, DHEAS, and sex-hormone-binding globulin (SHBG) were measured by radioimmunoassay before the study. Total T, free T, SHBG, and DHEAS were also measured at 6-month intervals far 1 year. Multiscreen blood chemistry and side effects were evaluated during the treatment. Result(s): Thirty-four patients completed the 12-month study period. A significant decrease in the hirsutism score as compared to baseline was observed after 12 months with both Diane 35 treatment (mean +/- SD, 15.62 +/- 4.89 vs. 9.75 +/- 3.97) and Diane 35 plus finasteride treatment (16.27 +/- 6.90 vs. 8.38 +/- 4.44). The percentage decreases in the hirsutism score (mean percent +/- SD) were 30.26 +/- 14.56 vs. 34.70 +/- 11.60 at 6 months, 38.09 +/- 11.46 vs. 48.14 +/- 14.27 at 22 months in the Diane 35 and the Diane 35 plus finasteride groups, respectively. The percentage reduction in the hirsutism score in the Diane 35 plus finasteride group at 12 months was greater than in the Diane 35 group (P <.05). Conclusion(s): The percentage decrease in the hirsutism score at 12 months was higher in the Diane 35 plus finasteride group than in the Diane 35 group. We believe that Diane 35 plus finasteride is an effective and safe combination for the treatment of hirsutism. (C) 2001 by American Society for Reproductive Medicine.
引用
收藏
页码:496 / 500
页数:5
相关论文
共 19 条
[1]
CRYPROTERONE ACETATE FOR SEVERE HIRSUTISM - RESULTS OF A DOUBLE-BLIND DOSE-RANGING STUDY [J].
BARTH, JH ;
CHERRY, CA ;
WOJNAROWSKA, F ;
DAWBER, RPR .
CLINICAL ENDOCRINOLOGY, 1991, 35 (01) :5-10
[2]
Finasteride treatment for one year in 35 hirsute patients [J].
Bayram, F ;
Müderris, II ;
Sahin, Y ;
Kelestimur, F .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 (03) :195-197
[3]
BELISLE S, 1986, FERTIL STERIL, V46, P1015
[4]
Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up [J].
Castello, R ;
Negri, C ;
Tosi, F ;
Muggeo, M ;
Perrone, F ;
Moghetti, P .
FERTILITY AND STERILITY, 1996, 66 (05) :734-740
[5]
The clinical management of hirsutism [J].
Conn, JJ ;
Jacobs, HS .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (04) :339-348
[6]
THE EFFECT OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR, ON SCALP SKIN TESTOSTERONE AND DIHYDROTESTOSTERONE CONCENTRATIONS IN PATIENTS WITH MALE PATTERN BALDNESS [J].
DALLOB, AL ;
SADICK, NS ;
UNGER, W ;
LIPERT, S ;
GEISSLER, LA ;
GREGOIRE, SL ;
NGUYEN, HH ;
MOORE, EC ;
TANAKA, WK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (03) :703-706
[7]
Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism [J].
Erenus, M ;
Yucelten, D ;
Durmusoglu, F ;
Gurbuz, O .
FERTILITY AND STERILITY, 1997, 68 (06) :1000-1003
[8]
EFFECTS OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR, ON CIRCULATING ANDROGENS AND GONADOTROPIN-SECRETION IN HIRSUTE WOMEN [J].
FRUZZETTI, F ;
DELORENZO, D ;
PARRINI, D ;
RICCI, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (03) :831-835
[9]
Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects [J].
Fruzzetti, F ;
Bersi, C ;
Parrini, D ;
Ricci, C ;
Genazzani, AR .
FERTILITY AND STERILITY, 1999, 71 (03) :445-451
[10]
HIRSUTISM - IMPLICATIONS, ETIOLOGY, AND MANAGEMENT [J].
HATCH, R ;
ROSENFIELD, RL ;
KIM, MH ;
TREDWAY, D .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 140 (07) :815-830